Irinotecan HCL Injection is used alone or in a combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine.) Irinotecan is in a class of antineoplastic medications called topoisomerase I inhibitors which works by stopping the growth of cancer cells. This product is in a liquid form and is given intravenously over a 90 minute time period. Irinotecan is sometimes used with other medications to treat small cell lung cancer.
STORAGE: Irinotecan injection should be stored at room temperature, but not to exceed 86 F, this is NOT A REFIGERATED PRODUCT. Expiration Dating is 24 months.
|RX PRODUCT||NCD#||STRENGTH||SIZE||PRODUCT CLASS||ADMINISTRATION||CASE SIZE|
|Irinotecan HCL Injection||59923-702-02||40 mg||2 ml||antineoplastic||IV||100|
|Irinotecan HCL Injection||59923-702-05||100 mg||5 ml||antineoplastic||IV||100|
J-Code: J9206 • Latex Free • Bar Code Information on each sell unit – 128 readable • AP bioequivalent parenteral product
|Wholesaler||Irinotecan 40mg/2ml||Irinotecan 100mg/5ml|
|Download Product Information|
|Irinotecan Injection 40mg-2ml package insert|
|Irinotecan Product Brochure|
|Irinotecan Package Configuration|